Freeman Brian J C
Centre for Spinal Studies and Surgery, Queen's Medical Centre, University Hospital, Nottingham, UK.
Eur Spine J. 2006 Aug;15 Suppl 3(Suppl 3):S448-57. doi: 10.1007/s00586-006-0156-2. Epub 2006 Jul 26.
Smith and Nephew (Endoscopy division, Andover, MA, USA) have estimated that 60,000 Intra-Discal Electrothermal Therapy (IDET) procedures have been performed world wide up to June 2005. Despite the large number of procedures performed, a critical appraisal of the evidence of efficacy of IDET has not appeared in the literature. This paper reviews the current evidence of clinical efficacy for IDET obtained via a systematic review of the literature. Studies were included if they used at least one of four specified primary outcome measures; pain intensity as assessed by a visual analogue score (VAS), global measurement of overall improvement, back specific functional status such as Oswestry disability Index (ODI) and return to work. Levels of evidence were assigned according to the hierarchy described by the Oxford Centre for Evidence-Based Medicine (www.cebm.net). Papers addressing possible mechanisms of action of IDET were not considered as the focus of the literature review was clinical effectiveness. Eleven prospective cohort studies (level II evidence) were reported on a total of 256 patients with a mean follow-up of 17.1 months (range 12-28 months). The mean improvement in the VAS for back pain was 3.4 points (range 1.4-6.5) and the mean improvement in ODI was 5.2 points (range 4.0-6.4). A total of 379 patients were reported in five retrospective studies (level III evidence). Between 13 and 23% of patients subsequently underwent surgery for low back pain within the study period. Two randomised controlled trials of IDET have been reported in the literature. The first randomised 64 patients (37 to IDET, 27 to Sham). The advantage for IDET patients amounted to 1.3 points on the VAS and seven points on the ODI. The second study randomised 57 subjects (38 to IDET, 19 to Sham) and showed no benefit from IDET over placebo. The evidence for efficacy of IDET remains weak and has not passed the standard of scientific proof.
施乐辉公司(美国马萨诸塞州安多弗市内窥镜部门)估计,截至2005年6月,全球范围内已进行了60000例椎间盘内电热疗法(IDET)手术。尽管手术例数众多,但关于IDET疗效证据的批判性评估尚未见诸文献。本文通过对文献的系统回顾,审视了目前IDET临床疗效的证据。若研究使用了四种指定主要结局指标中的至少一种,则纳入研究;这四种指标为:通过视觉模拟评分(VAS)评估的疼痛强度、整体改善的综合衡量、诸如Oswestry功能障碍指数(ODI)等背部特定功能状态以及恢复工作情况。证据水平根据牛津循证医学中心(www.cebm.net)所描述的等级划分来确定。由于文献综述的重点是临床疗效,因此未考虑探讨IDET可能作用机制的论文。共报告了11项前瞻性队列研究(II级证据),涉及256例患者,平均随访17.1个月(范围12 - 28个月)。背痛VAS的平均改善为3.4分(范围1.4 - 6.5),ODI的平均改善为5.2分(范围4.0 - 6.4)。五项回顾性研究(III级证据)共报告了379例患者。在研究期间,13%至23%的患者随后因腰痛接受了手术。文献中报告了两项IDET的随机对照试验。第一项试验将64例患者随机分组(37例接受IDET,27例接受假手术)。接受IDET治疗的患者在VAS上的优势为1.3分,在ODI上为7分。第二项研究将57名受试者随机分组(38例接受IDET,19例接受假手术),结果显示IDET并不比安慰剂更具优势。IDET疗效的证据仍然薄弱,尚未达到科学证明的标准。